AdaptHealth
AHCO
Market cap $1.2B

8.92 USD

-0.21

2.30%

Updated Jul 31, 11:24 AM EDT

1 day

-2.30%

5 days

-3.88%

1 month

-5.41%

3 months

4.82%

6 months

-17.56%

Year to date

-8.04%

1 year

-21.48%

5 years

-54.21%

10 years

-8.04%

About: AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Employees: 10,500

Healthcare Medical Devices

0

Funds holding %

of 7,324 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

104% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 26

15% more capital invested

Capital invested by funds: $1.25B [Q4 2024] → $1.44B (+$190M) [Q1 2025]

13% more funds holding

Funds holding: 200 [Q4 2024] → 225 (+25) [Q1 2025]

9% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 65

0.99% more ownership

Funds ownership: 97.42% [Q4 2024] → 98.41% (+0.99%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]

31% less call options, than puts

Call options by funds: $68.2M | Put options by funds: $99M

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$13

46%

upside

Avg. target

$13

46%

upside

High target

$13

46%

upside

2 analyst ratings

2 positive

100%

0 neutral

0%

0 negative

0%

Truist Securities David Macdonald	46%upside $13	Buy Maintained	12 May 2025
RBC Capital Ben Hendrix	46%upside $13	Outperform Maintained	8 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about AHCO published over the past 30 days

Zacks Investment Research

AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?

AdaptHealth (AHCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?

AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2025 financial results before the opening of the financial markets on Tuesday, August 5, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analyst.

AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call

Zacks Investment Research

Is the Options Market Predicting a Spike in AdaptHealth Stock?

Investors need to pay close attention to AHCO stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in AdaptHealth Stock?

Stock Picks From Seeking Alpha's June 2025 New Analysts

June saw a record number of 48 new Seeking Alpha analysts, each bringing fresh stock ideas and unique backgrounds to the platform. Analysts provided ratings from Sell to Buy, with detailed justifications based on market trends, company fundamentals, and sector-specific challenges. Key investment theses include bullish views on Alphabet, TSM, AppLovin, and Rolls-Royce, a bearish call Samsara, and a neutral stance on SoundHound AI.

Stock Picks From Seeking Alpha's June 2025 New Analysts

AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced that it has closed on the previously disclosed disposition of certain infusion assets in its Wellness at Home segment to a third party. The transaction was completed earlier this month. “The disposition of certain infusion asset.

AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt

AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care

AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers.

AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care

AdaptHealth Corp. to Participate in Upcoming Investor Conferences

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Barclays Leveraged Finance Conference, being held in Austin, on Tuesday, May 20, 2025. The RBCCM Global Healthcare Conference, being held in New.

AdaptHealth Corp. to Participate in Upcoming Investor Conferences

AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript

AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Suzanne Foster - CEO Jason Clemens - CFO Conference Call Participants Meghan Holtz - Jefferies Pito Chickering - Deutsche Bank Eric Coldwell - Baird Kevin Caliendo - UBS Ben Hendrix - RBC Capital Markets Mathew Blackman - Stifel Whit Mayo - Leerink Partners John Pinney - Canaccord Genuity Operator Good day, everyone, and welcome to today's AdaptHealth First Quarter 2025 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.

AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript

Zacks Investment Research

AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.

AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates

AdaptHealth Corp. Announces First Quarter 2025 Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of.

AdaptHealth Corp. Announces First Quarter 2025 Results

See News Rankings

Charts implemented using Lightweight Charts™